Notice to stakeholders: Considerations regarding the proposed use of psilocybin mushrooms in clinical trials, or as a drug accessed through the Special Access Program (SAP) - Notice to stakeholders: Considerations regarding the proposed use of psilocybin mushrooms in clinical trials, or as a drug accessed through the Special Access Program (SAP)

Additional Information

Field	Value
Data last updated	October 22, 2024
Metadata last updated	October 22, 2024
Created	October 22, 2024
Format	HTML
License	Open Government Licence - Canada
Has views	False
Id	0e284eb2-1706-4919-8c4c-ef9ef483831e
Package id	dcc16b25-2917-40df-b4cd-8a3fb444a12c
Position	1
State	active